SNDX Cash & Short-Term Investments
Syndax Pharmaceuticals Inc · Cash & Short-Term Investments
SNDX Cash & Short-Term Investments
Latest reported$413.69Mperiod ending
SNDX FY Cash & Short-Term Investments ($4.31M → $413.69M)
Annual Cash & Short-Term Investments
High-resolution chart · PNG
SNDX cash & short-term investments history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Short-Term Investments (USD) |
|---|---|
| 413,686,000 | |
| 582,913,000 | |
| 577,583,000 | |
| 484,397,000 | |
| 446,830,000 | |
| 293,065,000 | |
| 59,775,000 | |
| 80,911,000 | |
| 133,220,000 | |
| 105,330,000 | |
| 87,294,000 | |
| 12,208,000 | |
| 14,264,000 | |
| 628,000 | |
| 4,314,000 |